| P2093 | author name string | Christian Ries | |
| P2860 | cites work | Molecular characterization and expression of the gene encoding human erythroid-potentiating activity | Q24299977 |
| | Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity | Q24300114 |
| | Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein | Q24300127 |
| | JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD | Q24309017 |
| | Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4 | Q24322566 |
| | MicroRNAs: target recognition and regulatory functions | Q24609584 |
| | Disruption of epithelial cell-matrix interactions induces apoptosis | Q24673611 |
| | Tissue inhibitors of metalloproteinases | Q26829539 |
| | Multilineage potential of adult human mesenchymal stem cells | Q27860737 |
| | Wnt/beta-catenin signaling in development and disease | Q27860784 |
| | Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase | Q28145921 |
| | A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 | Q28185858 |
| | TIMP-2: an endogenous inhibitor of angiogenesis | Q28239198 |
| | The ADAM metalloproteinases | Q28292696 |
| | Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation | Q28483470 |
| | Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal | Q28583482 |
| | Mechanisms of angiogenesis | Q29547485 |
| | New functions for the matrix metalloproteinases in cancer progression | Q29547738 |
| | Matrix metalloproteinases and the regulation of tissue remodelling | Q29618747 |
| | Matrix metalloproteinases: regulators of the tumor microenvironment | Q29619858 |
| | Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene | Q30442174 |
| | A new role for TIMP-1 in modulating neurite outgrowth and morphology of cortical neurons | Q33518510 |
| | Progress in matrix metalloproteinase research | Q33608536 |
| | Down-regulation of tissue inhibitor of metalloproteinase-3 (TIMP-3) expression is necessary for adipocyte differentiation | Q33673738 |
| | Tissue inhibitor of metalloproteinase-3 (TIMP-3) regulates hematopoiesis and bone formation in vivo | Q33717003 |
| | The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity | Q33786342 |
| | TIMP-1 induces an EMT-like phenotypic conversion in MDCK cells independent of its MMP-inhibitory domain | Q34305749 |
| | Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. | Q34418845 |
| | Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by beta-amyloid 25-35 fragment | Q48731650 |
| | Timp-1 is important for epithelial proliferation and branching morphogenesis during mouse mammary development. | Q52175987 |
| | Plasma or serum TIMP-1 is a predictor of survival outcomes in colorectal cancer: a meta-analysis. | Q53089486 |
| | Silencing tissue inhibitors of metalloproteinases (TIMPs) with short interfering RNA reveals a role for TIMP-1 in hepatic stellate cell proliferation. | Q53269768 |
| | TIMP-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms. | Q53363489 |
| | Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10. | Q54357444 |
| | Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis | Q56890821 |
| | Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent | Q57554505 |
| | Inhibition of Angiogenesis and Murine Hemangioma Growth by Batimastat, a Synthetic Inhibitor of Matrix Metalloproteinases | Q60043764 |
| | Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients | Q60156243 |
| | Bone loss induced by Runx2 Over-expression in mice is blunted by osteoblastic over-expression of TIMP-1 | Q62084091 |
| | Blood sampling affects circulating TIMP-1 concentration, a useful biomarker in estimating liver fibrosis stages | Q62632403 |
| | Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors | Q64377824 |
| | Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity | Q67531378 |
| | Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2) | Q67674017 |
| | Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases | Q68042979 |
| | Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family | Q69752161 |
| | Characterization of purified human erythroid-potentiating activity | Q69966253 |
| | Purification and characterization of human T-lymphocyte-derived erythroid-potentiating activity | Q70223496 |
| | Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells | Q73336761 |
| | The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism | Q73694298 |
| | Recombinant TIMP-1 and -2 enhance the proliferation of rabbit corneal epithelial cells in vitro and the spreading of rabbit corneal epithelium in situ | Q74210939 |
| | Biophysical and functional characterization of full-length, recombinant human tissue inhibitor of metalloproteinases-2 (TIMP-2) produced in Escherichia coli. Comparison of wild type and amino-terminal alanine appended variant with implications for t | Q78010533 |
| | Tissue inhibitor of metalloproteinase-2 induces apoptosis in human T lymphocytes | Q78027332 |
| | Plasma TGF-beta1, TIMP-1, MMP-1 and IL-18 as a combined biomarker of psoriasis activity | Q79775795 |
| | Inhibition of osteoblastic metalloproteinases in mice prevents bone loss induced by oestrogen deficiency | Q81003328 |
| | TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis | Q81619161 |
| | Usefulness of Plasma Tissue Inhibitors of Metalloproteinases as Markers of Prognosis After Acute Myocardial Infarction | Q84689269 |
| | The prognostic value of TIMP-1 in multiple myeloma | Q84823675 |
| | Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: a potential oncogenic activity of tissue inhibitor of metalloproteinase-1 | Q95800349 |
| | Tissue inhibitor of metalloproteinase-2(TIMP-2)-deficient mice display motor deficits. | Q34546831 |
| | Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus | Q34785842 |
| | High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agents | Q35005245 |
| | TIMP-1 deficiency subverts cell-cycle dynamics in murine long-term HSCs | Q35067597 |
| | Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion | Q35186457 |
| | TIMPs as multifacial proteins | Q35703646 |
| | Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates mesenchymal stem cells through let-7f microRNA and Wnt/β-catenin signaling | Q35750890 |
| | Metalloproteinases and their inhibitors in tumor angiogenesis | Q36053766 |
| | Tissue inhibitor of metalloproteinases-1 protects human neurons from staurosporine and HIV-1-induced apoptosis: mechanisms and relevance to HIV-1-associated dementia | Q36071981 |
| | Plasma markers for identifying patients with metastatic melanoma | Q36152030 |
| | TIMP1 induces CD44 expression and the activation and nuclear translocation of SHP1 during the late centrocyte/post-germinal center B cell differentiation. | Q36250977 |
| | Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. | Q36805538 |
| | The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2. | Q37023899 |
| | TIMP-1 as a tumor marker in breast cancer--an update | Q37157590 |
| | Trafficking and function of the tetraspanin CD63. | Q37302224 |
| | Signal transduction by focal adhesion kinase in cancer | Q37377635 |
| | In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. | Q37388134 |
| | Tissue inhibitor of metalloproteinase-1 promotes NIH3T3 fibroblast proliferation by activating p-Akt and cell cycle progression | Q37599459 |
| | TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'. | Q37607436 |
| | Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle | Q37659597 |
| | Novel biomarkers in human terminal heart failure and under mechanical circulatory support | Q37894731 |
| | Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis | Q37963722 |
| | Cell surface engineering of renal cell carcinoma with glycosylphosphatidylinositol-anchored TIMP-1 blocks TGF- β 1 activation and reduces regulatory ID gene expression | Q38315551 |
| | A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family | Q38326523 |
| | Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells | Q39633829 |
| | Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α | Q39635479 |
| | Is tissue inhibitor of metalloproteinase-1 a new prognosticator for breast cancer? An analysis of 266 cases. | Q39643810 |
| | Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis | Q39801237 |
| | Tissue inhibitor of metalloproteinase-1 protects MCF-7 breast cancer cells from paclitaxel-induced apoptosis by decreasing the stability of cyclin B1. | Q39824199 |
| | Peritumoral administration of GPI-anchored TIMP-1 inhibits colon carcinoma growth in Rag-2 gamma chain-deficient mice | Q39832672 |
| | TIMP-1 binding to proMMP-9/CD44 complex localized at the cell surface promotes erythroid cell survival | Q39916675 |
| | TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro | Q39940587 |
| | Collagenase production by human skin fibroblasts | Q39940982 |
| | Inhibition of human collagenase activity by a small molecular weight serum protein | Q39955879 |
| | Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling. | Q40079532 |
| | Tissue inhibitor of metalloproteinase-1 promotes hematopoietic differentiation via caspase-3 upstream the MEKK1/MEK6/p38alpha pathway. | Q40170860 |
| | MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. | Q40188347 |
| | Tissue inhibitor of metalloproteinase-2 (TIMP-2) expression is regulated by multiple neural differentiation signals | Q40262226 |
| | Tissue inhibitor of matrix metalloproteinase-1 suppresses apoptosis of mouse bone marrow stromal cell line MBA-1. | Q40280755 |
| | TIMP-1 regulation of cell cycle in human breast epithelial cells via stabilization of p27(KIP1) protein | Q40330917 |
| | GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing | Q40356020 |
| | Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors | Q40505079 |
| | TIMP-1 stimulates proliferation of human aortic smooth muscle cells and Ras effector pathways | Q40508178 |
| | Exogenously added GPI-anchored tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) displays enhanced and novel biological activities | Q40524187 |
| | Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation. | Q40582557 |
| | Tissue inhibitor of metalloproteinases-1 signalling pathway leading to erythroid cell survival | Q40663813 |
| | TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis | Q40757054 |
| | Involvement of the p38 mitogen-activated protein kinase pathway in tissue inhibitor of metalloproteinases-1-induced erythroid differentiation | Q40840061 |
| | TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis | Q41065511 |
| | Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. | Q41125251 |
| | Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. | Q41259344 |
| | Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). | Q41445433 |
| | Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity. | Q41582012 |
| | Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum | Q41639433 |
| | Blood vessel density in de novo formed adipose tissue is decreased upon overexpression of TIMP-1. | Q42834154 |
| | Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and beta-cells | Q43596012 |
| | Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis | Q43858122 |
| | The tissue inhibitor of metalloproteinases-1 improves migration and adhesion of hematopoietic stem and progenitor cells | Q43915254 |
| | Both tissue inhibitors of metalloproteinases-1 (TIMP-1) and TIMP-2 activate Ras but through different pathways | Q44082343 |
| | Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker. | Q44100420 |
| | A crucial role for Lyn in TIMP-1 erythroid cell survival signalling pathway | Q44397868 |
| | TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism | Q44530445 |
| | Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway | Q44540466 |
| | Retinoids and TIMP1 prevent radiation-induced apoptosis of capillary endothelial cells | Q44733965 |
| | The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity | Q44749166 |
| | The expression of tissue inhibitor of metalloproteinase 2 (TIMP-2) is required for normal development of zebrafish embryos | Q47074151 |
| | Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells. | Q47725173 |
| | Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival | Q47832318 |
| | Overexpression of TIMP-1 in embryonic stem cells attenuates adverse cardiac remodeling following myocardial infarction | Q47980596 |
| | Wnt signaling regulates the invasion capacity of human mesenchymal stem cells | Q48088586 |
| P433 | issue | 4 | |
| P304 | page(s) | 659-672 | |
| P577 | publication date | 2013-08-28 | |
| P1433 | published in | Cellular and Molecular Life Sciences | Q5058352 |
| P1476 | title | Cytokine functions of TIMP-1. | |
| P478 | volume | 71 | |